7CA:FRA
Camurus AB
€57.55
arrow_upward
+2.31%(+1.30) 1D
Jul 17, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 7CA...
Open
€56.00
High
€57.55
Low
€56.00
Mkt. cap
38.06B
Avg. vol.
21.00
Volume
150.00
52-wk high
€67.80
52-wk low
€40.60
No. of employees
316
Open
€56.00
High
€57.55
Low
€56.00
Mkt. cap
38.06B
Avg. vol.
21.00
Volume
150.00
52-wk high
€67.80
52-wk low
€40.60
No. of employees
316
News stories
From sources across the web
TipRanks
·
1 day ago
Camurus’ Acromegaly Drug CAM2029 Resubmission Accepted by U.S. FDA
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB
CEOFredrik Tiberg
Employees316
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitecamurus.com
AI content may include mistakes. Learn more